Now, a new and potentially safer method of treatment has been introduced.
This medication, rivaroxaban, has been used to treat atrial fibrillation in the prevention of strokes and after knee and hip surgery. While it is not approved for the treatment of deep vein thrombosis or pulmonary embolism in the U.S., it is approved for the prevention of DVT formation. For more information on this topic visit our medical resource center.